Literature DB >> 33925074

Oral Mucosa as a Potential Site for Diagnosis and Treatment of Allergic and Autoimmune Diseases.

Cristina Gomez-Casado1, Javier Sanchez-Solares1, Elena Izquierdo1, Araceli Díaz-Perales2, Domingo Barber1, María M Escribese1.   

Abstract

Most prevalent food allergies during early childhood are caused by foods with a high allergenic protein content, such as milk, egg, nuts, or fish. In older subjects, some respiratory allergies progressively lead to food-induced allergic reactions, which can be severe, such as urticaria or asthma. Oral mucosa remodeling has been recently proven to be a feature of severe allergic phenotypes and autoimmune diseases. This remodeling process includes epithelial barrier disruption and the release of inflammatory signals. Although little is known about the immune processes taking place in the oral mucosa, there are a few reports describing the oral mucosa-associated immune system. In this review, we will provide an overview of the recent knowledge about the role of the oral mucosa in food-induced allergic reactions, as well as in severe respiratory allergies or food-induced autoimmune diseases, such as celiac disease.

Entities:  

Keywords:  autoimmune disease; celiac disease; desensitization; diagnosis; food allergy; inflammatory disease; oral mucosa; systemic disease; treatment

Year:  2021        PMID: 33925074     DOI: 10.3390/foods10050970

Source DB:  PubMed          Journal:  Foods        ISSN: 2304-8158


  233 in total

Review 1.  Barrier properties of mucus.

Authors:  Richard A Cone
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

Review 2.  Regulation of tight junction permeability by intestinal bacteria and dietary components.

Authors:  Dulantha Ulluwishewa; Rachel C Anderson; Warren C McNabb; Paul J Moughan; Jerry M Wells; Nicole C Roy
Journal:  J Nutr       Date:  2011-03-23       Impact factor: 4.798

Review 3.  Advance in oral delivery systems for therapeutic protein.

Authors:  Shiming He; Zhongcheng Liu; Donggang Xu
Journal:  J Drug Target       Date:  2018-07-17       Impact factor: 5.121

4.  The oral mucosa: A barrier site participating in tissue-specific and systemic immunity.

Authors:  N M Moutsopoulos; H M Moutsopoulos
Journal:  Oral Dis       Date:  2018-03       Impact factor: 3.511

Review 5.  Properties of Cell Sources in Tissue-Engineered Three-dimensional Oral Mucosa Model: A Review.

Authors:  Nurul Hafizah Mohd Nor; Zurairah Berahim; Azlina Ahmad; Thirumulu Ponnuraj Kannan
Journal:  Curr Stem Cell Res Ther       Date:  2017       Impact factor: 3.828

Review 6.  Cytokine regulation of tight junctions.

Authors:  Christopher T Capaldo; Asma Nusrat
Journal:  Biochim Biophys Acta       Date:  2008-10-08

7.  Potential role of the IL-33/ST2 axis in celiac disease.

Authors:  M A López-Casado; P Lorite; T Palomeque; M I Torres
Journal:  Cell Mol Immunol       Date:  2015-09-07       Impact factor: 11.530

8.  Influence of retinoic acid on human gingival epithelial barriers.

Authors:  S Groeger; F Jarzina; A Windhorst; J Meyle
Journal:  J Periodontal Res       Date:  2016-02-01       Impact factor: 4.419

9.  Phenotype and Tissue Residency of Lymphocytes in the Murine Oral Mucosa.

Authors:  Joo-Young Park; Hyunsoo Chung; Youngnim Choi; Jung-Hyun Park
Journal:  Front Immunol       Date:  2017-03-08       Impact factor: 7.561

10.  Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.

Authors:  Joanne R Chalmers; Rachel H Haines; Lucy E Bradshaw; Alan A Montgomery; Kim S Thomas; Sara J Brown; Matthew J Ridd; Sandra Lawton; Eric L Simpson; Michael J Cork; Tracey H Sach; Carsten Flohr; Eleanor J Mitchell; Richard Swinden; Stella Tarr; Susan Davies-Jones; Nicola Jay; Maeve M Kelleher; Michael R Perkin; Robert J Boyle; Hywel C Williams
Journal:  Lancet       Date:  2020-02-19       Impact factor: 202.731

View more
  1 in total

1.  Oropharyngeal symptoms without systemic reactions as a risk factor for food allergen intolerance: a longitudinal pediatric study.

Authors:  Masaaki Hamada; Keigo Saeki; Yoshihiko Sakurai
Journal:  Allergy Asthma Clin Immunol       Date:  2022-04-18       Impact factor: 3.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.